Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)
W F Rigby, T Stacy, M W Fanger, W F Rigby, T Stacy, M W Fanger
Abstract
Recent studies have suggested that vitamin D may have other important biologic activities in addition to its well-characterized role in the maintenance of calcium homeostasis. Discovery of cytosolic receptors for vitamin D in human peripheral blood monocytes and lectin-stimulated lymphocytes prompted us to study the effects of 1,25-dihydroxyvitamin D3 (calcitriol), the most biologically active metabolite of vitamin D, upon phytohemagglutinin (PHA)-induced lymphocyte blast transformation. We have found that calcitriol is a potent inhibitor of PHA-induced lymphocyte proliferation, achieving 70% inhibition of tritiated thymidine incorporation after 72 h in culture. Furthermore, calcitriol suppressed interleukin-2 (IL-2) production by PHA-stimulated peripheral blood mononuclear cells in a concentration-dependent fashion. Lastly, the suppressive effect of calcitriol on cellular proliferation was partially reversed by the addition of saturating amounts of purified IL-2. We conclude that calcitriol is a potent inhibitor of PHA-induced lymphocyte blast transformation and that this effect is mediated, in part, through suppression of IL-2 production. Thus, calcitriol appears to possess immunoregulatory properties that have been unappreciated heretofore.
References
- Int J Cancer. 1976 May 15;17(5):565-77
- Eur J Immunol. 1975 Apr;5(4):259-62
- J Immunol. 1978 Jun;120(6):2027-32
- J Immunol. 1979 Oct;123(4):1624-31
- Ann Intern Med. 1980 Mar;92(3):406-16
- Biochem Biophys Res Commun. 1980 Jul 31;95(2):596-602
- Immunol Rev. 1980;51:337-57
- J Exp Med. 1981 Nov 1;154(5):1455-74
- Proc Natl Acad Sci U S A. 1981 Aug;78(8):4990-4
- Biochem Biophys Res Commun. 1981 Oct 15;102(3):937-43
- Endocr Rev. 1982 Fall;3(4):331-66
- Proc Natl Acad Sci U S A. 1983 Jan;80(1):201-4
- Science. 1983 Sep 16;221(4616):1181-3
- J Immunol. 1983 Oct;131(4):1808-15
- J Clin Endocrinol Metab. 1983 Dec;57(6):1308-10
- J Clin Invest. 1983 Nov;72(5):1856-60
- J Clin Invest. 1984 Mar;73(3):731-9
Source: PubMed